Clinical Trial Update: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LHRH analogue therapy in combination with enzalutamide or bicalutamide for hormone-sensitive prostate cancer has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-10